- Home
- EDRY vs SLGL Comparison
EDRY vs SLGL Comparison
Compare EDRY & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- SLGL
- Stock Information
- Founded
- EDRY 2018
- SLGL 1997
- Country
- EDRY Greece
- SLGL Israel
- Employees
- EDRY N/A
- SLGL N/A
- Industry
- EDRY Marine Transportation
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- EDRY Consumer Discretionary
- SLGL Health Care
- Exchange
- EDRY Nasdaq
- SLGL Nasdaq
- Market Cap
- EDRY 31.7M
- SLGL 17.0M
- IPO Year
- EDRY N/A
- SLGL 2018
- Fundamental
- Price
- EDRY $10.78
- SLGL $0.62
- Analyst Decision
- EDRY
- SLGL Strong Buy
- Analyst Count
- EDRY 0
- SLGL 2
- Target Price
- EDRY N/A
- SLGL $5.00
- AVG Volume (30 Days)
- EDRY 7.5K
- SLGL 44.1K
- Earning Date
- EDRY 02-24-2025
- SLGL 03-21-2025
- Dividend Yield
- EDRY N/A
- SLGL N/A
- EPS Growth
- EDRY N/A
- SLGL N/A
- EPS
- EDRY N/A
- SLGL N/A
- Revenue
- EDRY $61,083,227.00
- SLGL $11,707,000.00
- Revenue This Year
- EDRY N/A
- SLGL $772.97
- Revenue Next Year
- EDRY $27.93
- SLGL N/A
- P/E Ratio
- EDRY N/A
- SLGL N/A
- Revenue Growth
- EDRY 28.35
- SLGL 869.93
- 52 Week Low
- EDRY $10.04
- SLGL $0.33
- 52 Week High
- EDRY $24.84
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- EDRY 43.93
- SLGL 43.15
- Support Level
- EDRY $10.51
- SLGL $0.55
- Resistance Level
- EDRY $11.18
- SLGL $0.70
- Average True Range (ATR)
- EDRY 0.37
- SLGL 0.07
- MACD
- EDRY 0.02
- SLGL 0.01
- Stochastic Oscillator
- EDRY 1.83
- SLGL 37.15
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.